Ozempic Shortage Leaves Diabetics Struggling to Manage Condition

A global shortage of the diabetes drug Ozempic is causing concern for diabetics in Ontario, Canada, who rely on the medication for their health. The shortage is partly attributed to the off-label use of Ozempic for weight loss, which has increased demand. Health Canada has not approved Ozempic for weight loss. The shortage is expected to persist until March 2024. Diabetics are struggling to find pharmacies with the medication in stock, leading to potential health consequences. Pharmacists are also facing challenges in fulfilling prescriptions due to the shortage. The use of Ozempic for weight loss has been driven by social media trends, particularly on TikTok. Experts are urging clinicians to prioritize prescriptions for patients with diabetes or serious health concerns related to obesity. The manufacturer, Novo Nordisk, has apologized for the shortage and encouraged patients to discuss alternatives with their healthcare providers. Health Canada is exploring ways to conserve existing supply and expedite resupplies to pharmacies.